Search
News
Earnings
Hercules Capital Q3 2026 Earnings: NII Covers the Base Distribution by 118%
Hercules Capital (NYSE: HTGC) reported Q3 2026 net investment income of $87.3 million, or $0.47 per share, covering its base cash distribution by 118%. For the first nine months, total investment income increased 9.0% to $430.8 million and NII rose 5.4% to $268.4 million. Year-to-date commitments reached $3.44 billion, while fundings totaled $1.93 billion. Assets under management grew 17.7% to approximately $6.5 billion, liquidity exceeded $1.0 billion including adviser-managed funds, and net GAAP leverage stood at 109.0%.TradingKey
Thu, Oct 29
Market Movers
Home Depot Inc Stock (HD) Closed Up by 3.60% on Oct 29: A Full Analysis
• Home Depot shares gained momentum as value-focused institutional buying emerged following oversold conditions. • Strong professional contractor demand helped insulate the company from constrained consumer retail spending. • Annual revenue reached $164.68B, with analysts maintaining an average price target of $372.86.
TradingKey
Thu, Oct 29
Market Movers
Gilead Sciences Inc Stock (GILD) Closed Up by 4.03% on Oct 29: Drivers Behind the Movement
• Gilead shares rose ahead of third-quarter financial results driven by therapy expectations. • Strategic pipeline updates and long-acting agents enhanced medium-term investor confidence. • Analysts raised price targets while technical indicators suggested buying conditions.
TradingKey
Thu, Oct 29
Earnings
ATEC Q3 2026 Earnings: Biologics Weakness Limits Revenue Growth
ATEC’s Q3 2026 revenue rose 12.6% to $221.2 million, and GAAP diluted loss per share narrowed to $0.03 from $0.19. Surgical revenue increased 14% to $202 million, supported by 17% hardware growth, approximately 20% case growth, and 25% growth in new surgeon users, but lower biologics attachment limited revenue conversion. GAAP gross margin improved 160 basis points to 71.5%, while adjusted EBITDA climbed to $38.3 million, or 17.3% of revenue. ATEC now targets about $862 million of 2026 revenue, $137 million of adjusted EBITDA, and $10 million of free cash flow.
TradingKey
Thu, Oct 29
Market Movers
Novartis AG Stock (NVS) Closed Up by 3.22% on Oct 29: Drivers Behind the Movement
• Novartis upgraded its full-year core operating income outlook to growth. • Key therapeutic brands achieved double-digit expansion offsetting generic competition. • Technical indicators show a MACD buy signal and overbought conditions.
TradingKey
Thu, Oct 29
Earnings
Edison International Q3 2026 Earnings: Core EPS Falls as Prior-Year Rate-Case Benefit Fades
Edison International’s (NYSE: EIX) Q3 2026 operating revenue fell 15.0% year over year to $4.886 billion, while basic GAAP EPS declined to $1.88 from $2.16 and non-GAAP core EPS dropped to $1.92 from $2.34. The comparison was pressured by earnings recognized in Q3 2025 when Southern California Edison implemented its rate-case decision retroactively, partly offset by authorized revenue escalation. Edison reaffirmed 2026 core EPS guidance of $5.90 to $6.20 and its 5% to 7% core EPS growth outlook through 2030.
TradingKey
Thu, Oct 29
Earnings
Sandisk Q1 FY2027 Earnings: Datacenter Growth Drives Revenue Higher
Sandisk’s fiscal Q1 2027 revenue climbed 378% year over year to $11.03 billion, while GAAP diluted EPS rose to $52.60 from $0.75. GAAP gross margin expanded to 85.0%, and datacenter revenue reached $4.80 billion after rising 61% sequentially, accounting for most of the company’s quarter-over-quarter revenue increase. Operating cash flow was $6.36 billion, supporting $5.0 billion of share repurchases. For fiscal Q2 2027, Sandisk guided to revenue of $12.2 billion to $12.6 billion and non-GAAP diluted EPS of $55.00 to $57.00 on a pre-split basis.
TradingKey
Thu, Oct 29
Earnings
AXT Q3 2026 Earnings: Indium Phosphide Demand Drives a Profit Turnaround
AXT (Nasdaq: AXTI) reported Q3 2026 revenue of $73.4 million, up 162% year over year, while GAAP diluted EPS swung to $0.39 from a $0.04 loss. GAAP gross margin expanded to 56.0% from 22.3%, and operating income reached $28.4 million versus a $1.1 million loss. Management attributed record revenue to exceptionally strong indium phosphide demand, productivity gains, and expanded large-diameter product capabilities. Investors now need to assess demand and margin durability, capacity execution, export-permit risk, and the higher diluted share count.
TradingKey
Thu, Oct 29
Earnings
Floor & Decor Q3 2026 Earnings: EPS Rises Despite Lower Comparable Sales
Floor & Decor’s fiscal Q3 2026 net sales rose 3.0% to $1,214.6 million while comparable-store sales fell 1.4%. Diluted EPS increased 15.1% to $0.61, supported by a 30-basis-point operating-margin gain, lower taxes, and fewer diluted shares. The company generated $485.3 million of operating cash flow over the first 39 weeks and updated its 53-week fiscal 2026 outlook to $4.765 billion-$4.835 billion of sales and $2.19-$2.29 of GAAP diluted EPS, even as full-year comparable sales are expected to remain negative.
TradingKey
Thu, Oct 29
Earnings
Exelixis Q3 2026 Earnings: Cabozantinib Sales Lift Profit
Exelixis (NASDAQ: EXEL) reported Q3 2026 revenue of $658.7 million, up about 10% from a year earlier, as net product revenue rose to $604.9 million on higher cabozantinib volume and pricing. GAAP diluted EPS increased to $0.85 from $0.69, while GAAP net income reached $218.1 million despite higher R&D and SG&A spending. The company maintained its 2026 revenue and expense ranges, lowered its effective tax-rate outlook to 16%-18%, and excluded potential zanzalintinib launch revenue. The FDA’s updated PDUFA date is March 3, 2027.
TradingKey
Thu, Oct 29
Earnings
Twilio Q3 2026 Earnings: Revenue Rises 20% as Operating Profit Expands
Twilio’s Q3 2026 revenue rose 20% year over year to $1.56 billion, including 16% organic growth, while GAAP diluted EPS increased to $1.00 from $0.23. GAAP operating income reached $148.6 million and free cash flow rose to $369.6 million, helped by operating expenses growing much more slowly than revenue. Dollar-based net expansion improved to 114%. Twilio also raised its full-year 2026 revenue growth, non-GAAP operating income, and free cash flow outlooks, although Q4 organic revenue growth guidance of 11% to 12% points to moderation from Q3.
TradingKey
Thu, Oct 29
Earnings
The Bancorp Q3 2026 Earnings: Fintech Fee Growth Offsets Net Interest Margin Pressure
The Bancorp’s Q3 2026 earnings showed approximately $175.9 million in revenue, up about 0.7% year over year, while diluted EPS rose 29.7% to $1.53. Total fintech fees increased 19.2% to $41.8 million and card GDV grew 23.4%, offsetting a decline in net interest income and a 70-basis-point contraction in net interest margin to 3.75%. GAAP net income reached $62.8 million, while adjusted net income increased 9.9% to $60.4 million. Management maintained 2026 Core EPS guidance of $5.95 to $6.05 per share.
TradingKey
Thu, Oct 29
Earnings
Schneider Q3 2026 Earnings: Truckload Profit Growth Lifts Margins
Schneider National’s Q3 2026 operating revenue rose 9% to $1.585 billion, while diluted EPS increased to $0.28 from $0.11 and adjusted EPS reached $0.29. Operating income climbed 76% to $62.1 million as Truckload pricing, productivity, cost synergies, and equipment utilization improved, with Intermodal earnings also growing. Logistics revenue increased 12%, but higher purchased transportation and claim-related insurance costs reduced segment operating income to break-even. Schneider raised full-year adjusted EPS guidance to $1.00-$1.10 and set net capital expenditure guidance at $325-$350 million.
TradingKey
Thu, Oct 29
Earnings
Pinterest Q3 2026 Earnings: Revenue Rises 12% as GAAP Profit Falls
Pinterest’s Q3 2026 revenue increased 12% year over year to $1.174 billion, while diluted GAAP EPS declined to $0.04 from $0.13. Global monthly active users reached a record 661 million, up 10%, but Europe’s revenue remained flat despite user growth and companywide GAAP profitability weakened as costs grew faster than sales. U.S. and Canada revenue supplied most of the quarter’s dollar increase, while Q4 guidance calls for 8% to 12% revenue growth and assumes a modest foreign-exchange headwind.
TradingKey
Thu, Oct 29
Earnings
Pebblebrook Q3 2026 Earnings: RevPAR Growth Lifts Hotel EBITDA
Pebblebrook Hotel Trust (NYSE: PEB) reported Q3 2026 revenue of $402.7 million, up about 1.0% year over year, while GAAP diluted EPS widened to a $0.56 loss from a $0.37 loss. On a same-property basis, RevPAR rose 8.3% and hotel EBITDA increased 15.1% to $115.2 million as room rates grew and expenses increased more slowly than revenue. A $77.3 million non-cash impairment weighed on GAAP results, but adjusted FFO per share rose 23.5% to $0.63, and the company raised its full-year adjusted EBITDAre, FFO, and free-cash-flow outlooks.
TradingKey
Thu, Oct 29
Earnings
Coinbase Q3 2026 Earnings: Crypto Gains Drive a Wide GAAP-Adjusted Profit Gap
Coinbase (COIN) reported Q3 2026 GAAP net income of $718.7 million, up about 66% year over year, but adjusted net income was $77.7 million after excluding crypto and investment gains. Adjusted EBITDA reached $332.9 million, up 60% sequentially but about 58% below Q3 2025. Crypto trading volume market share rose to 10.7%, prediction markets exceeded $200 million in annualized revenue, and subscription and services generated 49% of net revenue. The supplied release did not provide total revenue or EPS.
TradingKey
Thu, Oct 29
Earnings
PTC Therapeutics Q3 2026 Earnings: Sephience Drives Revenue as ST-920 Costs Weigh on Profit
PTC Therapeutics’ Q3 2026 revenue rose about 70% year over year to $357.8 million, while diluted EPS swung to a $0.62 loss from $0.20 in earnings. Product revenue more than doubled to $275.9 million, led by $181.9 million from Sephience, but a $111.0 million acquired in-process R&D charge tied to ST-920 and higher financing costs produced a $51.7 million net loss. PTC raised full-year product revenue guidance to $960 million-$990 million and ended September with $2.13 billion in cash, cash equivalents, and marketable securities.
TradingKey
Thu, Oct 29
Earnings
Olin Q3 2026 Earnings: Sales Edge Higher as Profit Falls
Olin Corporation’s Q3 2026 sales rose about 2.0% year over year to $1.75 billion, but diluted EPS fell to $0.13 from $0.37 and adjusted EBITDA declined 13.9% to $191.4 million. Growth in Epoxy and Winchester did not fully offset lower Chlor Alkali Products and Vinyls earnings, which were hurt by VCM operating issues and a smaller hydrogen tax-credit benefit. Olin expects Q4 adjusted EBITDA of $80 million to $100 million as customer destocking, higher feedstock costs, Asian export pressure, and planned maintenance weigh on the near-term outlook.
TradingKey
Thu, Oct 29
Featured Tools
Top News
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due
Nasdaq Extends Drop by 0.91% as Tech Stocks Lead Declines, AMD Falls Nearly 9%, Nvidia Drops 2%
Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
